Here's Why CNP Stock Deserves a Place in Your Portfolio Right Now

Zacks names CenterPoint Energy (CNP) a Zacks Rank #2 (Buy), citing a 2025 EPS estimate of $1.76 (+8.6%) and revenue of $9.18 billion (+6.2%), with a long‑term EPS growth target of 7–9% and a 3–5 year projection of ~7.9% driven by rising electrification and renewable investment. The firm touts CNP’s $65 billion 10‑year capital plan (with $10 billion in incremental opportunities), expected >11% annual rate‑base growth through 2030 and plans to recover roughly 85% of investments via forward test‑year cases and interim trackers, while highlighting a 2.19% dividend yield ($0.88 annually), ROE of 10.25%, Q3 times‑interest‑earned of 2.3 and a 28% share gain over the past year versus the industry—factors Zacks says support CNP as a compelling utility investment alongside peers FirstEnergy, Ameren and Alliant Energy.

Analysis

Zacks assigns CenterPoint Energy (CNP) a Rank #2 (Buy) driven by a 2025 EPS consensus of $1.76, implying +8.64% year‑over‑year, and revenue of $9.18 billion (+6.16%), with management targeting 7–9% long‑term EPS growth and Zacks projecting ~7.93% for the next 3–5 years. The company has laid out a $65 billion, 10‑year capital plan (including $10 billion incremental opportunities) and expects rate base to grow >11% annually through 2030, planning to recover roughly 85% of investment via forward test‑year rate cases and interim trackers; rising electrification and renewable investment are cited as demand drivers.

CenterPoint returns cash via a $0.22 quarterly dividend ($0.88 annualized, 2.19% yield) and shows an ROE of 10.25% versus the industry 9.95%, while shares have risen 28% over the past year versus industry +20.6%. Its times interest earned (TIE) was 2.3 at Q3 2025, indicating modest interest coverage despite commentary that debt management has improved.

The thesis is growth plus regulated recoverability, but execution and regulatory risk are material since ~85% capex recovery depends on rate cases and trackers; modest TIE also increases sensitivity to higher rates or earnings pressure. Relative peer data (FE, AEE, LNT) show mixed growth profiles, underscoring the need for active sector allocation and monitoring of regulatory milestones and financing metrics.

Key Decisions for Investors

• Consider adding or overweighting CNP on valuation pullbacks given the Zacks Buy, 2025 EPS upside (+8.64%), and the company’s 11%+ rate base growth thesis,
• Monitor upcoming forward test‑year rate cases and interim tracker outcomes closely because recovery of ~85% of the $65 billion plan is the primary execution risk,
• Manage position size and hedge interest‑rate exposure or limit leverage given a modest TIE of 2.3 and potential sensitivity to higher rates or financing needs,
• Compare CNP versus peers such as Ameren (higher long‑term growth) and FirstEnergy/Alliant (mixed profiles) to tilt exposure between growth, yield, and regulatory execution risk